198 related articles for article (PubMed ID: 30639737)
1. In Vitro Oral Cavity Model for Screening the Disintegration Behavior of Orodispersible Films: A Bespoke Design.
Redfearn A; Scarpa M; Orlu M; Hanson B
J Pharm Sci; 2019 May; 108(5):1831-1836. PubMed ID: 30639737
[TBL] [Abstract][Full Text] [Related]
2. Key acceptability attributes of orodispersible films.
Scarpa M; Paudel A; Kloprogge F; Hsiao WK; Bresciani M; Gaisford S; Orlu M
Eur J Pharm Biopharm; 2018 Apr; 125():131-140. PubMed ID: 29355687
[TBL] [Abstract][Full Text] [Related]
3. Comparative study on disintegration methods for oral film preparations.
Speer I; Steiner D; Thabet Y; Breitkreutz J; Kwade A
Eur J Pharm Biopharm; 2018 Nov; 132():50-61. PubMed ID: 30201569
[TBL] [Abstract][Full Text] [Related]
4. Orodispersible Films for Compounding Pharmacies.
Ferreira AO; Brandão MAF; Raposo FJ; Polonini HC; Raposo NRB
Int J Pharm Compd; 2017; 21(6):454-461. PubMed ID: 29220334
[TBL] [Abstract][Full Text] [Related]
5. Comparative study on novel test systems to determine disintegration time of orodispersible films.
Preis M; Gronkowsky D; Grytzan D; Breitkreutz J
J Pharm Pharmacol; 2014 Aug; 66(8):1102-11. PubMed ID: 24673551
[TBL] [Abstract][Full Text] [Related]
6. Model-based description of disintegration time and dissolution rate of nanoparticle-loaded orodispersible films.
Steiner D; Finke JH; Kwade A
Eur J Pharm Sci; 2019 Apr; 132():18-26. PubMed ID: 30794870
[TBL] [Abstract][Full Text] [Related]
7. Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods.
Speer I; Preis M; Breitkreutz J
Eur J Pharm Biopharm; 2018 Aug; 129():66-73. PubMed ID: 29792911
[TBL] [Abstract][Full Text] [Related]
8. Trends in the production methods of orodispersible films.
Musazzi UM; Khalid GM; Selmin F; Minghetti P; Cilurzo F
Int J Pharm; 2020 Feb; 576():118963. PubMed ID: 31857185
[TBL] [Abstract][Full Text] [Related]
9. Outlining critical quality attributes (CQAs) as guidance for the development of orodispersible films.
Borges AF; Silva C; Coelho JF; Simões S
Pharm Dev Technol; 2017 Mar; 22(2):237-245. PubMed ID: 27346557
[TBL] [Abstract][Full Text] [Related]
10. Orodispersible films as a personalized dosage form for nursing home residents, an exploratory study.
Visser JC; Wibier L; Mekhaeil M; Woerdenbag HJ; Taxis K
Int J Clin Pharm; 2020 Apr; 42(2):436-444. PubMed ID: 32052239
[TBL] [Abstract][Full Text] [Related]
11. Orodispersible films and tablets with prednisolone microparticles.
Brniak W; Maślak E; Jachowicz R
Eur J Pharm Sci; 2015 Jul; 75():81-90. PubMed ID: 25889975
[TBL] [Abstract][Full Text] [Related]
12. Micronized Zaleplon Delivery via Orodispersible Film and Orodispersible Tablets.
Manda P; Popescu C; Juluri A; Janga K; Kakulamarri PR; Narishetty S; Narasimha Murthy S; Repka MA
AAPS PharmSciTech; 2018 Apr; 19(3):1358-1366. PubMed ID: 29352403
[TBL] [Abstract][Full Text] [Related]
13. Orodispersible Films: A Systematic Patent Review.
Gijare C; Deshpande A
Recent Pat Drug Deliv Formul; 2018; 12(2):110-120. PubMed ID: 29745346
[TBL] [Abstract][Full Text] [Related]
14. Disintegration time of orally dissolving films: various methodologies and
Saab M; Mehanna MM
Pharmazie; 2019 Apr; 74(4):227-230. PubMed ID: 30940306
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets.
Mahesparan VA; Bin Abd Razak FS; Ming LC; Uddin AH; Sarker MZI; Bin LK
Int J Pharm Compd; 2020; 24(2):148-155. PubMed ID: 32196477
[TBL] [Abstract][Full Text] [Related]
16. How to assess orodispersible film quality? A review of applied methods and their modifications.
Wasilewska K; Winnicka K
Acta Pharm; 2019 Jun; 69(2):155-176. PubMed ID: 31259725
[TBL] [Abstract][Full Text] [Related]
17. [Oral films as perspective dosage form].
Walicová V; Gajdziok J
Ceska Slov Farm; 2016; 65(1):15-21. PubMed ID: 27118500
[TBL] [Abstract][Full Text] [Related]
18. A new biorelevant dissolution method for orodispersible films.
Krampe R; Sieber D; Pein-Hackelbusch M; Breitkreutz J
Eur J Pharm Biopharm; 2016 Jan; 98():20-5. PubMed ID: 26515261
[TBL] [Abstract][Full Text] [Related]
19. Poly(methyl methacrylate) salt as film forming material to design orodispersible films.
Musazzi UM; Selmin F; Franzé S; Gennari CGM; Rocco P; Minghetti P; Cilurzo F
Eur J Pharm Sci; 2018 Mar; 115():37-42. PubMed ID: 29329745
[TBL] [Abstract][Full Text] [Related]
20. Development and Characterization of an Orodispersible Film for Vitamin D3 Supplementation.
Cupone IE; Dellera E; Marra F; Giori AM
Molecules; 2020 Dec; 25(24):. PubMed ID: 33322282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
